Celltrion Healthcare supplied Herzuma, a biosimilar targeting stomach and breast cancers, to Ukraine.
Celltrion applied to the European Medicines Agency (EMA) for approval for CT-P16, its biosimilar version of anticancer drug Avastin.
Korea JoongAng Daily Sitemap